We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ABVC market cap is 31.03M. The company's latest EPS is USD -0.2923 and P/E is -6.33.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2k | 1,000 | 117k | 390k | 2k |
| Operating Income | -1.96M | -3.44M | -977k | -97k | -333k |
| Net Income | -3.11M | -3.93M | -1.01M | -186k | 229k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 483k | 356k | 970k | 152k | 510k |
| Operating Income | -8.51M | -11.71M | -15.11M | -8.22M | -4.7M |
| Net Income | -9.79M | -12.84M | -16.42M | -10.52M | -4.9M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.49M | 14.46M | 14.63M | 14.46M | 7.54M |
| Total Liabilities | 6.36M | 6.97M | 6.81M | 6.48M | 6.82M |
| Total Equity | 8.13M | 7.49M | 7.83M | 7.98M | 724k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.61M | 13.7M | 9.86M | 14.49M | 7.54M |
| Total Liabilities | 8.95M | 4.83M | 6.62M | 6.36M | 6.82M |
| Total Equity | 2.66M | 8.87M | 3.24M | 8.13M | 724k |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.24M | -473k | -1.49M | -1.32M | -1.81M |
| Investing | -360k | N/A | N/A | N/A | N/A |
| Financing | 3.92M | 676k | 1.55M | 1.4M | 1.98M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.56M | -7.6M | -7.4M | -4.24M | -1.81M |
| Investing | -225k | -806k | -1.72M | -360k | N/A |
| Financing | 9.57M | 10M | 4.01M | 3.92M | 1.98M |
| Market Cap | 31.03M |
| Price to Earnings Ratio | -6.33 |
| Price to Sales Ratio | 60.86 |
| Price to Cash Ratio | 125 |
| Price to Book Ratio | 42.86 |
| Dividend Yield | - |
| Shares Outstanding | 16.77M |
| Average Volume (1 week) | 269.87k |
| Average Volume (1 Month) | 304.12k |
| 52 Week Change | 117.65% |
| 52 Week High | 1.85 |
| 52 Week Low | 0.40 |
| Spread (Intraday) | 0.14 (7.57%) |
| Company Name | ABVC BioPharma Inc |
| Address |
401 ryland st ste 200-a, reno reno, nevada 89502 |
| Website | https://www.abvcpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
